Subclinical inflammation, C-reactive protein & cardiovascular risk.

作者信息

Heald A H

机构信息

Department of Diabetes & Endocrinology University of Manchester Salford Royal Hospitals University Trust Hope Hospital, Stott Lane, Salford Greater Manchester, M6 8HD, U.K.

出版信息

Indian J Med Res. 2007 Apr;125(4):502-4.

PMID:17598934

Abstract

摘要

相似文献

Subclinical inflammation, C-reactive protein & cardiovascular risk.

Indian J Med Res. 2007 Apr;125(4):502-4.

Therapy and clinical trials.

Curr Opin Lipidol. 2006 Aug;17(4):492-4. doi: 10.1097/01.mol.0000236378.03744.9c.

Hot and bothered: C-reactive protein, inflammation and atherosclerosis.

Int J Clin Pract. 2009 Nov;63(11):1550-3. doi: 10.1111/j.1742-1241.2009.02211.x.

Cardiovascular disease. Does inflammation cut to the heart of the matter?

Science. 2002 Apr 12;296(5566):242-5. doi: 10.1126/science.296.5566.242.

Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation.

J Cardiopulm Rehabil Prev. 2011 May-Jun;31(3):137-45. doi: 10.1097/HCR.0b013e3182122827.

[Significance of C-reactive protein in asthma].

Przegl Lek. 2010;67(7):472-4.

What else does the JUPITER trial add regarding C-reactive protein and cardiovascular disease?

Int J Cardiol. 2011 Jun 16;149(3):387. doi: 10.1016/j.ijcard.2011.03.008. Epub 2011 Mar 30.

Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.

Expert Rev Mol Diagn. 2007 Nov;7(6):793-804. doi: 10.1586/14737159.7.6.793.

Biochemical risk markers: a novel area for better prediction of renal risk?

Nephrol Dial Transplant. 2005 Mar;20(3):497-508. doi: 10.1093/ndt/gfh680.

Cardiac biomarkers: myths, facts and future horizons.

Expert Rev Mol Diagn. 2007 Nov;7(6):693-7. doi: 10.1586/14737159.7.6.693.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Subclinical inflammation, C-reactive protein & cardiovascular risk.

Indian J Med Res. 2007 Apr;125(4):502-4.

Therapy and clinical trials.

Curr Opin Lipidol. 2006 Aug;17(4):492-4. doi: 10.1097/01.mol.0000236378.03744.9c.

Hot and bothered: C-reactive protein, inflammation and atherosclerosis.

Int J Clin Pract. 2009 Nov;63(11):1550-3. doi: 10.1111/j.1742-1241.2009.02211.x.

Cardiovascular disease. Does inflammation cut to the heart of the matter?

Science. 2002 Apr 12;296(5566):242-5. doi: 10.1126/science.296.5566.242.

Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation.

J Cardiopulm Rehabil Prev. 2011 May-Jun;31(3):137-45. doi: 10.1097/HCR.0b013e3182122827.

[Significance of C-reactive protein in asthma].

Przegl Lek. 2010;67(7):472-4.

What else does the JUPITER trial add regarding C-reactive protein and cardiovascular disease?

Int J Cardiol. 2011 Jun 16;149(3):387. doi: 10.1016/j.ijcard.2011.03.008. Epub 2011 Mar 30.

Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.

Expert Rev Mol Diagn. 2007 Nov;7(6):793-804. doi: 10.1586/14737159.7.6.793.

Biochemical risk markers: a novel area for better prediction of renal risk?

Nephrol Dial Transplant. 2005 Mar;20(3):497-508. doi: 10.1093/ndt/gfh680.

Cardiac biomarkers: myths, facts and future horizons.

Expert Rev Mol Diagn. 2007 Nov;7(6):693-7. doi: 10.1586/14737159.7.6.693.